MicroRNAs are expressed abundantly in the placenta throughout pregnancy. We have previously reported that microRNA (miR)-378a-5p promoted trophoblast migration and invasion. To further understand the role of miR-378a-5p during placental development, we investigated whether it may regulate the differentiation of syncytiotrophoblast (STB). Using a choriocarcinoma cell line, BeWo, we found that miR-378a-5p was down-regulated during forskolin-induced STB differentiation. Transfection of a miR-378a-5p mimic into BeWo cells decreased the formation of multinucleated STB, increased Ecadherin, and decreased the expression level of STB marker genes. On the other hand, transfection of anti-miR-378a-5p resulted in an increase in formation of multinucleated STB and expression of STB marker genes, as well as the loss of E-cadherin. Bioinformatic analysis revealed that miR-378a-5p has four potential binding sites at the 3 0 untranslated region (UTR) of cyclin G2 (CCNG2). Using luciferase reporter assays, we showed that miR-378a-5p decreased the luciferase activity of reporter constructs that contain CCNG2 3 0 UTR. In addition, miR-378a-5p decreased, whereas anti-miR-378a-5p increased, CCNG2 mRNA levels. Overexpression of CCNG2 increased the expression of syncytin-1 and fusion index and reversed the inhibitory effects of miR-378a-5p. In contrast, silencing of CCNG2 using siRNA increased E-cadherin and decreased syncytin-1 levels. These findings provide initial evidence that CCNG2 promotes STB differentiation and suggest that miR-378a-5p exerts an inhibitory role in STB differentiation, in part, by down-regulating CCNG2 expression, in the BeWo cell model. cell fusion, cyclin G2, miR-378a-5p, syncytiotrophoblast differentiation
INTRODUCTION
Placenta plays critical roles throughout the entire pregnancy and supports the growth and development of the fetus. During placental development, trophoblast progenitor cells differentiate into two distinct pathways [1, 2] . In the extravillous (EVT) or invasive pathway, cytotrophoblast (CTB) differentiates into invasive EVT cells that penetrate into the maternal decidua and myometrium. In the villous or syncytial pathway, fusion of mononuclear CTB results in the formation of a multinucleated syncytiotrophoblast (STB), and this process is referred to as syncytialization [2] .
The multinucleated STB is formed by the fusion of underlying mononucleated CTBs, and this process is accompanied by the loss of E-cadherin [3] . Two fusogenic retroviral envelope proteins, syncytin-1 (encoded by HERV-W) and syncytin-2 (encoded by HERV-FRD), are responsible for the fusion of CTBs into STB [4, 5] . Galactoside-binding soluble lectin 13 (LGALS13, also known as PP13), predominantly localized to the STB apical membrane [6] , and placental alkaline phosphatase (ALPP or PALP), an enzyme produced by STB, are often used as markers of STB differentiation [7] . In addition, STB synthesizes and secrets hormones, such as human chorionic gonadotropin (hCG) [8] . The differentiation of STB is regulated by many factors [9] , including two transcription factors, glial cells missing-1 (GCM-1) and peroxisome proliferator-activated receptor gamma (PPARc) [10] [11] [12] .
Human cyclin G2 (CCNG2) is an unconventional cyclin that inhibits cell cycle progression [13] [14] [15] [16] . CCNG2 levels are increased during growth inhibition [14] and cell differentiation [15] . It has also been reported that CCNG2 induces adipocyte differentiation by interacting with PPARc to enhance its transcriptional activity [15] . Recently, CCNG2 was found to be expressed in human placenta with an increased level in midgestational stage and then to decrease sharply at term [17] . Immunohistochemical analysis of CCNG2 in placenta revealed that it is highly expressed in term placentae obtained from compromised pregnancy, such as pregnancy involving preeclampsia or gestational diabetes mellitus, as compared to placentae from healthy subjects [17] . However, the function of CCNG2 in placenta is unknown.
MicroRNAs are naturally occurring small noncoding RNAs that regulate gene expression at the posttranscriptional levels [18, 19] . MicroRNAs regulate many developmental events, including placental development [2, [20] [21] [22] . Recent studies have shown that miRNAs regulate proliferation, migration, invasion, and differentiation of human trophoblast cells [1, 2, [23] [24] [25] [26] . We have previously demonstrated that microRNA (miR)-378a-5p promotes trophoblast cell proliferation, migration, and invasion [23] . To further understand the role of miR378a-5p in placental development, we investigated whether it also regulates trophoblast cell differentiation along the STB pathway, and explored the potential mechanisms by which miR-378a-5p controls STB differentiation. We demonstrated that miR-378a-5p inhibited STB differentiation, in part, by down-regulating CCNG2 expression.
MATERIALS AND METHODS

Cell Culture
A human choriocarcinoma cell line, BeWo, was purchased from American Type Culture Collection. Cells were cultured at 378C in a humidified atmosphere of 5% CO 2 in a 1:1 mixture of Dulbecco modified Eagle medium (DMEM; HyClone) and Ham F12 (Life Technologies) and supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 IU/ml penicillin, and 100 lg/ml streptomycin (all purchased from Life Technologies).
Forskolin Treatment
Cells were treated with different concentrations of forskolin (SigmaAldrich) for 48 h. BeWo cells were treated with forskolin (50 lM) or dimethyl sulfoxide (DMSO; final concentration 0.04%) as its vehicle control in the presence of 1% FBS. At the end of experiments, immunofluorescent staining, total RNA extraction, or protein lysate preparations were performed to determine the effect of forskolin on cell fusion, STB marker gene expression, and miR-378a-5p expression.
Transient Transfection
Transient transfection of plasmids, miRNA mimics, inhibitors, or siRNA was carried out using Lipofectamine 2000 or Lipofectamine RNAiMAX (Life Technologies) following the manufacturer's suggested procedures [25] . CCNG2 siRNA, nontargeting negative control (NC), and miR-378a-5p mimic were purchased from GenePharma Co. Anti-miR-378a-5p and its corresponding NC were purchased from RiboBio. Generation of CCNG2-expressing plasmid (p3XFLAG-CMV-7.1) was reported previously [16] . Two luciferase constructs containing different regions of CCNG2 3 0 untranslated region (UTR) were generated by PCR using primers listed in Table 1 . The resulting cDNA fragments were cloned into pMIR-Report (Ambion) downstream of the luciferase coding sequence. Construct-1 contains the first predicted site and construct-2 contains three other predicted sites of miR-378a-5p.
Immunofluorescence
BeWo cells were seeded on the coverslips in a 12-well plate at the density of 4 3 10 4 /well. The next day, cells were treated with 50 lM forskolin or transiently transfected with miR-378a-5p, anti-miR-378a-5p, CCNG2-expressing plasmid DNA, or their corresponding controls. At different time points after treatment or transfection, cells were fixed in methanol (À208C) for 10 min and washed three times with PBS. Cells were incubated with 3% BSA in PBS for 1 h, followed by mouse monoclonal anti-E-cadherin antibody (1:100; Santa Cruz Biotechnology) overnight at 48C. The coverslips were washed with PBS buffer and incubated with Alexa Fluor 594-conjugated goat anti-mouse secondary antibody (1:300; Life Technologies) at room temperature for 1 h. Cell nuclei were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI; 1:1000; Sigma) for 5 min. Finally, coverslips were washed, mounted, examined with the inverted fluorescence microscope, and photographed. Cell fusion was analyzed in six or seven randomly selected fields per coverslip and the number of cells having 3 or more nuclei was counted. Fusion index was calculated as ([N À S]/T) 3 100%, where N is the number of nuclei in the syncytia, S is the number of syncytia, and T is the total number of nuclei in the observed field, as described [27] .
RNA Extraction and Real-Time PCR
Total RNA was isolated using TRIzol reagent (Life Technologies) according to the manufacturer's instructions. For miR-378a-5p measurement, the TRIzol extraction protocol was modified to enrich the small RNA population as described [28] . To determine mRNA levels of CCNG2 and STB marker genes, 2 lg of total RNA was used to synthesize first-strand cDNA by M-MuLV Reverse Transcriptase (New England BioLabs Ltd.). Real-time PCR was carried out using gene-specific primers (Table 1) and SsoFast EvaGreen Supermix (Bio-Rad). The expression levels of mRNA were normalized to glyceraldehyde phosphate dehydrogenase (GAPDH) or b-actin. The quantitative PCR (qPCR) reactions included an initial denaturation step at 958C for 1 min, followed by 40 cycles of 20 sec at 958C, 30 sec at 608C, and 30 sec at 728C. Reverse transcription and real-time PCR for miR-378a-5p and its internal control U6 were carried out using TaqMan microRNA Reverse Transcription Kit and TaqMan PCR kits (Life Technologies), according to the manufacturer's instructions. The relative expression levels of mRNAs and miR-378a-5p were determined using the standard DDCt method.
Protein Extraction and Immunoblotting
Cells were washed with cold PBS (136 mM NaCl, 2.6 mM KCl, 10 mM Na 2 HPO 4 .7H 2 O, 1.8 mM KH 2 PO 4 , and pH was adjusted to 7.4) and cell lysate was prepared using radioimmunoprecipitation assay buffer (50 mM Tris HCl, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, and 1% SDS) containing Halt protease inhibitor cocktail (Pierce). Cell lysates were centrifuged at 12 000 3 g for 20 min at 48C. Protein concentration was determined by the bicinchoninic acid method. Equal amounts of protein samples (30 lg) were subjected to 10% SDS-PAGE and transferred onto polyvinylidene difluoride (PVDF; Bio Rad) membranes. The PVDF membranes were blocked with 5% milk in TBST (10 mM Tris-Cl pH 8.0, 150 mM NaCl, and 0.05% Tween 20) for 1 h at room temperature and then incubated with primary antibodies in blocking buffer overnight at 48C. Primary antibodies used were anti-E-cadherin (1:500; Santa Cruz), anti-syncytin-1 (1:500; Santa Cruz) and anti-GAPDH (1:5000; Santa Cruz). The membranes were washed with TBST and subsequently probed with horseradish peroxidase-conjugated secondary antibody at room temperature for 1 h. Signals were detected using ECL (Millipore) according to the manufacturer's protocol. To obtain quantitative data from Western blots, films were scanned and signal intensities were analyzed using the Carestream Molecular Imaging software. The densitometric intensities of E-cadherin were normalized to its respective GAPDH levels.
Luciferase Assay
Cells were seeded in 12-well plates at the density of 8 3 10 4 cells/well and cotransfected with 25 nM of NC or miR-378a-5p mimics, pMIR-Report-CCNG2 3 0 UTR plasmids, and pRL-TK internal control (encoding Renilla luciferase) plasmids. Five hours after transfection, cells were recovered in DMEM/F12 for another 19 h. Twenty-four hours after transfection, the cells were lysed and luciferase activities were measured using the Dual Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions.
Statistical Analysis
All the experiments were done at least three times with triplicates in each group. The results are expressed as mean 6 SEM. Statistical analysis was performed using SigmaStat software. Experiments with multiple groups were analyzed by one-way ANOVA, followed by Student-Newman-Keuls post hoc test. Student t-test was used for comparison between two groups. P , 0.05 was considered statistically significant.
RESULTS
miR-378a-5p is Down-Regulated During Forskolin-Induced STB Differentiation
It is well documented that activation of the cAMP pathway, such as addition of forskolin, induces BeWo cell fusion and STB marker gene expression [8] . To determine if miR-378a-5p is regulated during STB differentiation, BeWo cells were treated with control or different concentrations of forskolin (25, 50, and 100 lM) for 48 h; immunofluorescent staining with an antibody against E-cadherin revealed that forskolin strongly induced cell fusion (Fig. 1A) . Cells were also treated with 50 lM of forskolin for different time durations. Consistent with the effect of forskolin on cell fusion, there was a significant decrease in E-cadherin protein levels (Fig. 1B) and a significant increase in syncytin-1 mRNA levels (Fig. 1C ) at 48 and 72 h after treatment with forskolin. Meanwhile, forskolin also significantly decreased miR-378a-5p levels at 48-and 72-h time points (Fig. 1D) .
miR-378a-5p Inhibits Cell Fusion and STB Marker Gene Expression
Several sets of experiments were performed to determine if miR-378a-5p may play a role in STB differentiation. First, cells were transfected without (as a mock control) or with different concentrations of miR-378a-5p or NC and cell fusion was assessed by immunofluorescence at 72 h following transfection. As shown in Figure 2A , transfection with the miR-378a-5p mimic resulted in significant decrease of fusion index in a concentration-dependent manner, whereas there was no difference in cell fusion between the NC and mock controls. Next, cells were transfected with miR-378a-5p (200 nM) or the NC for 24 h and then treated with forskolin (50 lM) for 48 h. Immunofluorescent studies showed that miR-378a-5p significantly reduced cell fusion not only under basal condition, but also in forskolin-treated cells (Fig. 2B) . Similarly, Western blotting revealed that miR-378a-5p significantly increased Ecadherin expression in both control and forskolin-treated cells (Fig. 2C) . Finally, cells were transiently transfected with antimiR-378a-5p, and at 72 h after transfection, immunofluorescence and Western blot analyses were performed. Compared to mock transfection or NC, anti-miR-378a-5p significantly increased cell fusion (Fig. 2D) and decreased E-cadherin protein levels (Fig. 2E) .
To further evaluate the role of miR-378a-5p in STB differentiation, RT-qPCR was used to analyze the mRNA level of several STB marker genes, including syncytin-1, syncytin-2, ALPP, LGALS13, and CGB. Transfection of the miR-378a-5p mimic significantly decreased (Fig. 3A) , whereas transfection of anti-miR-378a-5p increased (Fig. 3B) , the mRNA levels of all these marker genes when data were normalized to GAPDH. Similar results were obtained when bactin was used to normalize the data (Supplemental Fig. S1 ; available online at www.biolreprod.org). Western blotting using a syncytin-1 antibody confirms that miR-378a-5p down-regulated, whereas anti-miR-378a-5p up-regulated, the expression of syncytin-1 (Fig. 3C) .
miR-378a-5p Targets CCNG2
To explore the mechanisms by which miR-378a-5p inhibits the differentiation of STB, bioinformatic tools were used to examine the predicted target genes of miR-378a-5p. FindTar3 (bio.sz.tsinghua.edu.cn) predicted five potential binding sites of miR-378a-5p at the 3 0 UTR of CCNG2. Four of the sites were also predicted by microRNA.org (Fig. 4A) . Because CCNG2 is known to induce adipocyte differentiation [15] and its expression in the placenta has been recently reported [17] , we hypothesized that CCNG2 may promote STB differentiation and may be down-regulated by miR-378a-5p. To test this possibility, luciferase reporter assay was first performed. Two CCNG2 3 0 UTR fragments containing different targeting sites of miR-378a-5p were cloned into the pMIR-REPORT vector. Cells were cotransfected with a control reporter without 3 0 UTR or one of the CCNG2 constructs, along with miR-378a-5p mimic or its NC or mock controls. Luciferase assays were performed at 24 h after transfection. MicroRNA-378a-5p significantly decreased the luciferase activity when cells were transfected with a CCNG2 3 0 UTR constructs; however, it did not affect the activity of a control plasmid that does not contain CCNG2 3 0 UTR sequence (Fig. 4B ). To further confirm that miR-378a-5p regulates CCNG2, BeWo cells were transiently transfected with miR-378a-5p mimic or anti-miR-378a-5p or their corresponding controls, total RNA was extracted at 72 h after transfection, and mRNA level of CCNG2 was determined by RT-qPCR. Figure 4C shows that CCNG2 mRNA levels were significantly lower in cells transfected with miR-378a-5p than in control cells. Conversely, cells transfected with anti-miR-378a-5p had a significantly higher CCNG2 mRNA level than control cells (Fig. 4C) .
To determine if CCNG2 regulates STB differentiation, cells were transfected with control plasmid vector or plasmid expressing CCNG2. Cell lysates were prepared at 72 h after CCNG2 transfection and Western blot analyses were performed using anti-E-cadherin and anti-syncytin-1 antibodies. Overexpression of CCNG2 resulted in a significant inhibition of E-cadherin but a strong induction of syncytin-1 protein levels (Fig. 5A) . On the other hand, knockdown of CCNG2 expression using a siRNA-mediated gene-silencing approach increased E-cadherin and decreased syncytin-1 protein levels (Fig. 5A) . Immunofluorescent studies revealed that overexpression of CCNG2 increased cell fusion (Fig. 5B) . To confirm that miR-378a-5p exerts its inhibitory effect on STB differentiation by down-regulating, at least in part, CCNG2 expression, rescue experiments were performed. Again, forced overexpression of miR-378a-5p reduced fusion index. However, this effect was attenuated when cells were transfected with CCNG2-expressing plasmid (Fig. 5C ).
DISCUSSION
This study was carried out to further investigate the role of miR-378a-5p during placental development; specifically, to examine the potential role of miR-378a-5p in trophoblast cell differentiation into the syncytial pathway. We demonstrated that miR-378a-5p inhibits the STB differentiation and identified CCNG2 as a target gene of miR-378a-5p. These findings further support the notion that miR-378a-5p is an important regulator of human placental development. In addition, this study provides the first evidence that CCNG2 regulates trophoblast cell differentiation.
BeWo cells have been used extensively to study STB differentiation [8] . During STB differentiation, CTB cells fuse to form multinucleated STB cells, and this is accompanied by expression of STB-specific genes, such as syncytin-1, syncytin-2, ALPP, CGB, and LGALS13 [4] [5] [6] [7] 29] . In the present study, we used BeWo cells to examine the role of miR378a-5p in regulating cell fusion and STB marker gene expression.
Several lines of evidence support an inhibitory role of miR378a-5p in STB differentiation. First, miR-378a-5p levels were down-regulated during forskolin-induced STB differentiation. In addition, immunofluorescence results showed that miR378a-5p mimic significantly reduced, whereas anti-miR-378a-5p significantly increased, the number of cells that had multiple nuclei, indicating that miR-378a-5p inhibits cell fusion. Furthermore, mRNA levels of STB marker genes including syncytin-1, syncytin-2, CGB, ALPP, and LGALS13 were down-regulated by miR-378a-5p but up-regulated by anti-miR378a-5p. Finally, miR-378a-5p increased E-cadherin and miR-378a-5p INHIBITS TROPHOBLAST FUSION VIA CCNG2 FIG. 1. Forskolin induces STB differentiation and inhibits miR-378a-5p expression. A) Forskolin induces cell fusion. BeWo cells were treated with different concentrations of forskolin and immunofluorescent staining was performed at 48 h after treatment. Cell membranes were stained with anti-Ecadherin and nuclei were stained with DAPI (blue). Representative pictures of control and cells treated with 50 lM of forskolin are shown (magnification 3200). Fusion index was calculated based on the number of cells having three or more nuclei (n ¼ 3 wells in a representative experiment). B) Forskolin inhibits E-cadherin (E-cad) expression. Cells were treated with forskolin (50 lM) for 24, 48, and 72 h and Western blotting performed. Representative pictures and a summary graph are shown. C) Forskolin induces syncytin-1 mRNA expression. D) Forskolin inhibits miR-378a-5p expression. Data represent mean 6 SEM of three experiments. *P , 0.05, **P , 0.01, and ***P , 0.001 versus corresponding controls.
FIG. 2.
MicroRNA-378a-5p inhibits cell fusion. A) Cells were transfected without (mock) or with different concentrations of miR-378a-5p mimic or equal amount of the NC. Immunofluorescent staining using an anti-E-cadherin antibody was performed at 72 h after transfection. Representative pictures of E-cadherin merged with DAPI (blue) of mock, NC, or miR-378a-5p (200 nM) transfected cells and a summary graph (n ¼ 3 wells) are shown (magnification 3400). B) MicroRNA-378a-5p inhibits forskolin (FSK)-induced cell fusion. BeWo cells were transfected with miR-378a-5p (200 nM) or NC for 24 h and then treated with either DMSO or FSK (50 lM) for 48 h (n ¼ 3 wells). C) MicroRNA-378a-5p reverses the inhibitory effect of FSK on E-cadherin expression. Cells were transfected and treated as in B and cell lysates collected at 48 h after FSK treatment (n ¼ 3 experiments). D and E) Anti-miR-378a-5p miR-378a-5p INHIBITS TROPHOBLAST FUSION VIA CCNG2 FIG. 3 . MicroRNA-378a-5p inhibits STB marker gene expression. A, B) BeWo cells were transfected with miR-378a-5p mimic (200 nM) (A) or anti-miR378a-5p (B), or their mock and corresponding NC. Total RNA was extracted at 72 h after transfection and mRNA levels were determined by RT-qPCR. The marker gene mRNA levels were normalized to GAPDH. Data represent mean 6 SEM of three experiments. *P , 0.05, **P , 0.01, ***P , 0.001 versus corresponding mock and NC groups. C) MicroRNA-387a-5p inhibits whereas anti-miR-378a increases syncytin-1 protein levels. Cell lysates were collected at 72 h after transfection. 0 UTR downstream of the luciferase coding sequence, were generated. 3 0 UTR-1 contains the first predicted site and 3 0 UTR-2 contains the second to fourth predicted sites. Cells were transfected with the control reporter (pMIR-REPORT without 3 0 UTR) or a CCNG2 3 0 UTR construct, together with mock, NC, or miR-378a-5p. Luciferase assays were performed at 24 h after transfection. C) miR-378a-5p decreased, whereas anti-miR-378a-5p increased, CCNG2 mRNA levels. *P , 0.05, **P , 0.01 versus corresponding controls (n ¼ 3 experiments).
miR-378a-5p INHIBITS TROPHOBLAST FUSION VIA CCNG2 FIG. 5. CCNG2 induces STB differentiation. A) Representative immunoblots of E-cadherin, syncytin-1, and GAPDH levels and a summary graph in BeWo cells transfected with control plasmid vector (EV) or plasmid expressing CCNG2, without (mock) or with a siRNA targeting CCNG2 (siCCNG2) or its NC. Cell lysates were prepared at 72 h after transfection. Data represent mean 6 SEM (n ¼ 3). *P , 0.05, **P , 0.01 versus controls. B) Overexpression of CCNG2 induces cell fusion. Cells were transfected with EV or CCNG2 plasmid. Immunofluorescent studies were performed at 72 h after transfection, and fusion index (n ¼ 3) was calculated. Western blot analyses using cell lysates collected at 24 h after transfection confirm the overexpression of CCNG2. ***P , 0.001 versus EV. C) Overexpression of CCNG2 reverses the inhibitory effect of miR-378a-5p on cell fusion. Cells were transfected with NC or miR-decreased syncytin-1 protein expression levels and attenuated the effects of forskolin on cell fusion and STB marker gene expression. Taken together, these findings suggest that miR378a-5p is a negative regulator of STB differentiation.
This study identifies CCNG2 as a target gene of miR-378a-5p. The CCNG2 3 0 UTR contains four predicted binding sites for miR-378a-5p. Using luciferase reporter assays, we showed that miR-378a-5p decreased the luciferase activity of reporter constructs that contain CCNG2 3 0 UTR. In addition, miR-378a-5p decreased, whereas anti-miR-378a-5p increased, CCNG2 mRNA levels. Furthermore, knockdown of CCNG2 using siRNA mimicked the effect of miR-378a-5p in STB cell differentiation. On the other hand, overexpression of CCNG2 promoted STB differentiation and reversed the inhibitory effects of miR-378a-5p. Thus, it is likely that the inhibitory effect of miR-378a-5p on STB differentiation is mediated in part via the down-regulation of CCNG2.
It is well established that a miRNA can target many genes [30] . The validated targets of miR-378a-5p include Nodal [23] ; CYP19, which encodes aromatase [31] ; insulin-like growth factor I receptor (IGF1R) [32] ; SuFu and Fus-1 [33] ; and Nacetylgalactosaminyltransferase 7 (GalNT7) [34] . Some of these genes may be involved in STB differentiation. For example, Nodal has been shown to regulate placental trophoblast differentiation in mouse [35] . We have reported that Nodal inhibits trophoblast proliferation, migration, and invasion in human [13, 36, 37] and miR-378a-5p promotes trophoblast migration and invasion by suppressing Nodal expression [23] . Recently, Nodal was found to decrease Ecadherin levels in BeWo cells [38] . Interestingly, Nodal has been reported to up-regulate CCNG2 expression [39] . Thus, it is possible that Nodal may regulate CCNG2 to induce STB differentiation. Aromatase has also been identified as a target gene of miR-378 in porcine follicular cells [31] . STB differentiation is associated with marked induction of CYP19 gene expression and aromatase activity [40] . MicroRNA-17;92 and miR-106a;363 clusters have been reported to inhibit STB differentiation by targeting CYP19 [41] . Also, miR-378a-5p targets IGF1R in cardiac myocytes [32] and IGF-1 has been implicated in STB differentiation [42, 43] . It is likely that miR-378a-5p also target these genes in trophoblast to regulate STB differentiation.
One of the most significant findings from this study is the functional role of CCNG2 in trophoblasts. CCNG2 is known as an unconventional cyclin that inhibits cell cycle progression [13] [14] [15] [16] . Recently, its expression in human placenta was reported [17] ; however, the role of CCNG2 in human placenta remained unknown. In this study, we showed that overexpression of CCNG2 increased fusion index and syncytin-1 expression but decreased E-cadherin protein levels. These findings, together with the expression of CCNG2 in human STBs [17] , suggest that CCNG2 may promote the differentiation of STB during placental development. Interestingly, CCNG2 has also been detected in mouse uterus and suggested to play a role in implantation and decidualization [44] . Further studies are required to characterize the physiological role of CCNG2 during pregnancy.
A recent study demonstrated that CCNG2 interacts with PPARc to induce adipocyte differentiation. PPARc plays important roles in development and function of placenta [45] . Interestingly, PPARc was detected in STB and it increased the CGB mRNA levels and the secretion of hCG and other hormones, such as placental lactogen, growth hormone, and leptin [12] . Whether or not CCNG2 interacts with PPARc to promote STB differentiation will be investigated in the future.
Collectively, data obtained from this study strongly suggest that miR-378a-5p inhibits STB differentiation. We have previously demonstrated that miR-378a-5p enhanced trophoblast cell migration and invasion. It is, therefore, possible that miR-378a-5p promotes trophoblast cell differentiation into the invasive EVT pathway but prevents their differentiation into the STB pathway. More studies are required, especially using primary cultures of trophoblast cells prepared from healthy human placenta, to test this hypothesis.
